Medtronic, Inc. (MDT) Tops Q4 EPS by 1c; Guides FY13 Sales
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts MDT Hot Sheet
Price: $95.41 -1.22%
EPS Growth %: -2.2%
Financial Fact:
Amortization Of Intangible Assets: 89M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: -2.2%
Financial Fact:
Amortization Of Intangible Assets: 89M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Medtronic, Inc. (NYSE: MDT) reported Q4 EPS of $0.99, $0.01 better than the analyst estimate of $0.98. Revenue for the quarter came in at $4.3 billion versus the consensus estimate of $4.23 billion.
Medtronic, Inc. sees FY2013 EPS of $3.62-$3.70, versus the consensus of $3.66. Sees sales up 2-4 percent.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Medtronic, Inc. sees FY2013 EPS of $3.62-$3.70, versus the consensus of $3.66. Sees sales up 2-4 percent.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- RBC Capital Reiterates Outperform Rating on Verisk Analytics (VRSK)
- Bristol Myers Squibb MS CAR T therapy data shows patients off DMTs
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
